• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西海洋刺胞动物提取物及来自八放珊瑚虫Carijoa riisei的一种改良类固醇的抗原生动物活性。

Antiprotozoan activity of Brazilian marine cnidarian extracts and of a modified steroid from the octocoral Carijoa riisei.

作者信息

Reimão Juliana Quero, Migotto Alvaro Esteves, Kossuga Miriam H, Berlinck Roberto G S, Tempone André Gustavo

机构信息

Laboratório de Toxinologia Aplicada, Departamento de Parasitologia, Instituto Adolfo Lutz, Av. Dr. Arnaldo 351, 8 andar, Cerqueira Cesar, CEP 01246-000 São Paulo, São Paulo, Brazil.

出版信息

Parasitol Res. 2008 Nov;103(6):1445-50. doi: 10.1007/s00436-008-1154-6. Epub 2008 Sep 2.

DOI:10.1007/s00436-008-1154-6
PMID:18762984
Abstract

In the present investigation, we have evaluated the antileishmanial and antitrypanosomal activity of methanolic crude extracts obtained from eight species of cnidarians and of a modified steroid isolated from the octocoral Carijoa riisei. The antileishmanial activity of cnidarians crude extracts showed 50% inhibitory concentration (IC50) values in the concentration range between 2.8 and 93.3 microg/mL. Trypomastigotes of Trypanosoma cruzi were less susceptible to the crude extracts, with IC50 values in the concentration range between 40.9 and 117.9 microg/mL. The steroid (18-acetoxipregna-1,4,20-trien-3-one) displayed a strong antileishmanial activity, with an IC50 value of 5.5 microg/mL against promastigotes and 16.88 microg/mL against intracellular amastigotes. The steroid also displayed mammalian cytotoxicity (IC50 of 10.6 microg/mL), but no hemolytic activity was observed at the highest concentration of 12.5 microg/mL. The antileishmanial effect of the steroid in macrophages suggested other mechanism than macrophage activation, as no upregulation of nitric oxide was observed. The antitrypanosomal activity of the steroid resulted in an IC50 value of 50.5 microg/mL. These results indicate the potential of cnidarian natural compounds as antileishmanial drug candidates.

摘要

在本研究中,我们评估了从8种刺胞动物中获得的甲醇粗提物以及从八放珊瑚类的里氏卡里佐珊瑚(Carijoa riisei)中分离得到的一种修饰类固醇的抗利什曼原虫和抗锥虫活性。刺胞动物粗提物的抗利什曼原虫活性显示,其50%抑制浓度(IC50)值在2.8至93.3微克/毫升之间。克氏锥虫的无鞭毛体对粗提物的敏感性较低,IC50值在40.9至117.9微克/毫升之间。该类固醇(18 - 乙酰氧基孕甾 - 1,4,20 - 三烯 - 3 - 酮)表现出较强的抗利什曼原虫活性,对前鞭毛体的IC50值为5.5微克/毫升,对细胞内无鞭毛体的IC50值为16.88微克/毫升。该类固醇还表现出哺乳动物细胞毒性(IC50为10.6微克/毫升),但在最高浓度12.5微克/毫升时未观察到溶血活性。该类固醇在巨噬细胞中的抗利什曼原虫作用表明其作用机制并非巨噬细胞激活,因为未观察到一氧化氮的上调。该类固醇的抗锥虫活性导致IC50值为50.5微克/毫升。这些结果表明刺胞动物天然化合物作为抗利什曼原虫药物候选物的潜力。

相似文献

1
Antiprotozoan activity of Brazilian marine cnidarian extracts and of a modified steroid from the octocoral Carijoa riisei.巴西海洋刺胞动物提取物及来自八放珊瑚虫Carijoa riisei的一种改良类固醇的抗原生动物活性。
Parasitol Res. 2008 Nov;103(6):1445-50. doi: 10.1007/s00436-008-1154-6. Epub 2008 Sep 2.
2
Antileishmanial and trypanocidal activity of Brazilian Cerrado plants.巴西塞拉多植物的抗利什曼原虫和抗锥虫活性。
Mem Inst Oswaldo Cruz. 2005 Nov;100(7):783-7. doi: 10.1590/s0074-02762005000700019.
3
Antiprotozoal activity of Brazilian plant extracts from isoquinoline alkaloid-producing families.来自产异喹啉生物碱家族的巴西植物提取物的抗寄生虫活性。
Phytomedicine. 2005 May;12(5):382-90. doi: 10.1016/j.phymed.2003.10.007.
4
Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad Rhinella jimi parotoid macrogland secretion.从蟾蜍Rhinella jimi腮腺大腺分泌物中分离出的蟾蜍二烯羟酸内酯的抗利什曼原虫和抗锥虫活性。
Toxicon. 2008 Jul;52(1):13-21. doi: 10.1016/j.toxicon.2008.05.008. Epub 2008 Jul 15.
5
Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.新型 2,3-取代喹喔啉衍生物的合成及抗利什曼原虫和抗锥虫活性评价。
Eur J Med Chem. 2015 Jan 27;90:107-23. doi: 10.1016/j.ejmech.2014.11.018. Epub 2014 Nov 11.
6
Antitrypanosomal activity of isololiolide isolated from the marine hydroid Macrorhynchia philippina (Cnidaria, Hydrozoa).从菲律宾海葵(腔肠动物门,水螅纲)中分离得到的异柳杉内酯的抗锥虫活性。
Bioorg Chem. 2019 Aug;89:103002. doi: 10.1016/j.bioorg.2019.103002. Epub 2019 May 20.
7
Antiprotozoal activity of Khaya anthotheca, (Welv.) C.D.C. a plant used by chimpanzees for self-medication.药用植物黑檀治疗原虫感染的活性研究,这种植物被黑猩猩用于自我医疗。
J Ethnopharmacol. 2013 May 2;147(1):220-3. doi: 10.1016/j.jep.2013.03.007. Epub 2013 Mar 14.
8
Trypanocidal and leishmanicidal activities of flavonoids isolated from Stevia satureiifolia var. satureiifolia.从甜叶菊(Stevia satureiifolia var. satureiifolia)中分离出的黄酮类化合物的杀锥虫和杀利什曼原虫活性。
Pharm Biol. 2016 Oct;54(10):2188-95. doi: 10.3109/13880209.2016.1150304. Epub 2016 Mar 17.
9
In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae).从 Baccharis retusa DC.(菊科)中提取的类黄酮的抗利什曼原虫和抗锥虫活性的体外研究。
Exp Parasitol. 2012 Feb;130(2):141-5. doi: 10.1016/j.exppara.2011.11.002. Epub 2011 Nov 28.
10
Phytochemical and antiprotozoal activity of Ocotea lancifolia.披针叶樟的植物化学成分及抗原生动物活性
Fitoterapia. 2007 Jul;78(5):382-4. doi: 10.1016/j.fitote.2007.03.003. Epub 2007 Apr 11.

引用本文的文献

1
Cnidarians as a potential source of antiparasitic drugs.刺胞动物作为抗寄生虫药物的潜在来源。
Parasitol Res. 2022 Jan;121(1):35-48. doi: 10.1007/s00436-021-07387-2. Epub 2021 Nov 29.
2
Antifungal compounds with anticancer potential from Trichoderma sp. P8BDA1F1, an endophytic fungus from Begonia venosa.从 Begonia venosa 内生真菌 Trichoderma sp. P8BDA1F1 中提取具有抗癌潜力的抗真菌化合物。
Braz J Microbiol. 2020 Sep;51(3):989-997. doi: 10.1007/s42770-020-00270-9. Epub 2020 Apr 24.
3
Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.

本文引用的文献

1
Natural products to anti-trypanosomal drugs: an overview of new drug prototypes for American Trypanosomiasis.从天然产物到抗锥虫药物:美洲锥虫病新药原型概述
Cardiovasc Hematol Agents Med Chem. 2007 Jul;5(3):222-35. doi: 10.2174/187152507781058726.
2
Antimicrobial activity in the common seawhip, Leptogorgia virgulata (Cnidaria: Gorgonaceae).常见海鞭Leptogorgia virgulata(刺胞动物门:柳珊瑚科)中的抗菌活性。
Comp Biochem Physiol B Biochem Mol Biol. 2007 Sep;148(1):65-73. doi: 10.1016/j.cbpb.2007.04.019. Epub 2007 May 5.
3
Isolation of antileishmanial sterol from the fruits of Cassia fistula using bioguided fractionation.
筛选海洋天然产物以寻找针对原生动物和疟疾的新药先导物。
Mar Drugs. 2020 Mar 31;18(4):187. doi: 10.3390/md18040187.
4
Isolation, Derivative Synthesis, and Structure-Activity Relationships of Antiparasitic Bromopyrrole Alkaloids from the Marine Sponge Tedania brasiliensis.从海洋海绵 Tedania brasiliensis 中分离、衍生合成及抗寄生虫溴代吡咯生物碱的结构-活性关系研究。
J Nat Prod. 2018 Jan 26;81(1):188-202. doi: 10.1021/acs.jnatprod.7b00876. Epub 2018 Jan 3.
5
Antimicrobials from Cnidarians. A New Perspective for Anti-Infective Therapy?来自刺胞动物的抗菌剂。抗感染治疗的新视角?
Mar Drugs. 2016 Mar 8;14(3):48. doi: 10.3390/md14030048.
6
Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications.细胞毒性和细胞溶解的刺胞动物毒液。对健康影响和可能的治疗应用的综述。
Toxins (Basel). 2013 Dec 27;6(1):108-51. doi: 10.3390/toxins6010108.
7
Bioactive pregnane steroids from a South China Sea gorgonian Carijoa sp.南海柳珊瑚 Carijoa sp. 中的生物活性孕甾烷类化合物
Molecules. 2013 Mar 15;18(3):3458-66. doi: 10.3390/molecules18033458.
8
Molluscicidal activity of some marine substances against the snail Biomphalaria glabrata (Mollusca, Planorbidae).一些海洋物质对光滑滨螺(软体动物门,扁卷螺科)的杀螺活性。
Parasitol Res. 2012 May;110(5):1873-9. doi: 10.1007/s00436-011-2712-x. Epub 2011 Dec 29.
9
Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study.呋喃唑酮是一种针对利什曼原虫(L.)查加斯的体外选择性候选药物:超微结构研究。
Parasitol Res. 2010 May;106(6):1465-9. doi: 10.1007/s00436-010-1826-x. Epub 2010 Mar 30.
采用生物导向分级分离法从腊肠树果实中分离抗利什曼原虫甾醇。
Phytother Res. 2007 Jul;21(7):644-7. doi: 10.1002/ptr.2131.
4
Chagas disease.恰加斯病
Postgrad Med J. 2006 Dec;82(974):788-98. doi: 10.1136/pgmj.2006.047357.
5
Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis.从低肋叶泡蛙皮肤中分离具有抗菌活性的肽并进行生化特性分析。
Peptides. 2006 Dec;27(12):3092-9. doi: 10.1016/j.peptides.2006.08.005. Epub 2006 Sep 11.
6
Current scenario of drug development for leishmaniasis.利什曼病药物研发的现状
Indian J Med Res. 2006 Mar;123(3):399-410.
7
Marine natural products and related compounds in clinical and advanced preclinical trials.处于临床和临床前高级试验阶段的海洋天然产物及相关化合物。
J Nat Prod. 2004 Aug;67(8):1216-38. doi: 10.1021/np040031y.
8
Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.利什曼病——当前的化疗及新型药物研发的最新进展
Trends Parasitol. 2003 Nov;19(11):502-8. doi: 10.1016/j.pt.2003.09.008.
9
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.内脏利什曼病:控制、诊断和治疗的现状以及拟议的研发议程。
Lancet Infect Dis. 2002 Aug;2(8):494-501. doi: 10.1016/s1473-3099(02)00347-x.
10
Marine natural products.海洋天然产物
Nat Prod Rep. 2002 Feb;19(1):1-48. doi: 10.1039/b009029h.